158 related articles for article (PubMed ID: 25755249)
1. An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.
Gillespie MA; Gold ES; Ramsey SA; Podolsky I; Aderem A; Ranish JA
EMBO J; 2015 May; 34(9):1244-58. PubMed ID: 25755249
[TBL] [Abstract][Full Text] [Related]
2. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression.
Huwait EA; Greenow KR; Singh NN; Ramji DP
Cell Signal; 2011 Mar; 23(3):542-9. PubMed ID: 21070853
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-based "Two-pronged" approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux.
He H; Wang J; Yannie PJ; Korzun WJ; Yang H; Ghosh S
Biomaterials; 2020 Nov; 260():120333. PubMed ID: 32853832
[TBL] [Abstract][Full Text] [Related]
4. Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia/macrophages.
Zhang R; Dong Y; Liu Y; Moezzi D; Ghorbani S; Mirzaei R; Lozinski BM; Dunn JF; Yong VW; Xue M
Stroke Vasc Neurol; 2023 Dec; 8(6):486-502. PubMed ID: 37137522
[TBL] [Abstract][Full Text] [Related]
5. Flindissone, a Limonoid Isolated from
Resetar M; Tietcheu Galani BR; Tsamo AT; Chen Y; Schachner D; Stolzlechner S; Mawouma Pagna JI; Beniddir MA; Kirchmair J; Dirsch VM
J Nat Prod; 2023 Aug; 86(8):1901-1909. PubMed ID: 37526502
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptors at the intersection of lipid metabolism and atherogenesis.
Lee SD; Tontonoz P
Atherosclerosis; 2015 Sep; 242(1):29-36. PubMed ID: 26164157
[No Abstract] [Full Text] [Related]
7. A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.
Sonett J; Goldklang M; Sklepkiewicz P; Gerber A; Trischler J; Zelonina T; Westerterp M; Lemaître V; Okada Y; D'Armiento J
FASEB J; 2018 Jun; 32(12):fj201701381. PubMed ID: 29906247
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ATP binding cassette transporter A1 (ABCA1) expression: cholesterol-dependent and - independent signaling pathways with relevance to inflammatory lung disease.
He P; Gelissen IC; Ammit AJ
Respir Res; 2020 Sep; 21(1):250. PubMed ID: 32977800
[TBL] [Abstract][Full Text] [Related]
9. Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis.
He H; Yuan Q; Bie J; Wallace RL; Yannie PJ; Wang J; Lancina MG; Zolotarskaya OY; Korzun W; Yang H; Ghosh S
Transl Res; 2018 Mar; 193():13-30. PubMed ID: 29172034
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes.
Finno CJ; Bordbari MH; Valberg SJ; Lee D; Herron J; Hines K; Monsour T; Scott E; Bannasch DL; Mickelson J; Xu L
Free Radic Biol Med; 2016 Dec; 101():261-271. PubMed ID: 27751910
[TBL] [Abstract][Full Text] [Related]
11. LXR agonism for CNS diseases: promises and challenges.
Zhang R; Wuerch E; Yong VW; Xue M
J Neuroinflammation; 2024 Apr; 21(1):97. PubMed ID: 38627787
[TBL] [Abstract][Full Text] [Related]
12. New wrestling rules of anti-inflammatory transrepression by oxysterol receptor LXR revealed.
Treuter E
Cell Res; 2011 May; 21(5):711-4. PubMed ID: 21445093
[No Abstract] [Full Text] [Related]
13. Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche.
Peters EB; Karver MR; Sun K; Gillis DC; Biswas S; Clemons TD; He W; Tsihlis ND; Stupp SI; Kibbe MR
Adv Ther (Weinh); 2021 Sep; 4(9):. PubMed ID: 34926792
[TBL] [Abstract][Full Text] [Related]
14. NCOA5 Deficiency in Macrophages Provokes NASH and HCC.
Liu Y; Feng GS
Cell Mol Gastroenterol Hepatol; 2024; 17(1):171-172. PubMed ID: 37935378
[No Abstract] [Full Text] [Related]
15. Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis.
Varin A; Thomas C; Ishibashi M; Ménégaut L; Gautier T; Trousson A; Bergas V; de Barros JP; Narce M; Lobaccaro JM; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1357-65. PubMed ID: 25838428
[TBL] [Abstract][Full Text] [Related]
16. Cellular Cholesterol Accumulation Facilitates Ubiquitination and Lysosomal Degradation of Cell Surface-Resident ABCA1.
Mizuno T; Hayashi H; Kusuhara H
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1347-56. PubMed ID: 25838426
[TBL] [Abstract][Full Text] [Related]
17. Targeting liver X receptors in cancer therapeutics.
Lin CY; Gustafsson JÅ
Nat Rev Cancer; 2015 Apr; 15(4):216-24. PubMed ID: 25786697
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Macrophage Gene Expression via Liver X Receptor α Serine 198 Phosphorylation.
Wu C; Hussein MA; Shrestha E; Leone S; Aiyegbo MS; Lambert WM; Pourcet B; Cardozo T; Gustafson JA; Fisher EA; Pineda-Torra I; Garabedian MJ
Mol Cell Biol; 2015 Jun; 35(11):2024-34. PubMed ID: 25825525
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
Huang L; Fan B; Ma A; Shaul PW; Zhu H
J Lipid Res; 2015 May; 56(5):986-97. PubMed ID: 25761370
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
